How to Taper Venlafaxine
Venlafaxine must be tapered gradually when discontinuing treatment to minimize withdrawal symptoms, which can be severe and include dizziness, nausea, headache, fatigue, dysphoria, and in rare cases hallucinations. 1, 2
Recommended Tapering Approach
Standard Taper Protocol
Reduce the dose by 10% of the original dose per week as a reasonable starting point, though slower tapers (e.g., 10% per month) may be better tolerated, particularly for patients on long-term therapy 3. The FDA label explicitly warns that venlafaxine should be tapered when discontinuing because withdrawal syndrome has been well-described 1, 2.
Key Tapering Principles
- The first dose reduction is critical—it must go well to predict tolerance of the full taper 4
- Daily tiny reductions are superior to weekly larger steps: Recent prospective data shows that daily hyperbolic tapering (mean 4.5% per day or 25.3% per week) produces significantly less withdrawal than weekly steps (mean 33.4% per week), especially for shorter 1-3 month tapers 5
- Taper duration should be individualized based on withdrawal severity: Pause and restart the taper if withdrawal symptoms become problematic, and slow the rate once reaching lower doses 3
- Once the smallest available dose is reached, extend the interval between doses (e.g., every other day, then every third day) before complete discontinuation 3
Withdrawal Symptoms to Monitor
Watch for both somatic and psychological symptoms 6:
Somatic symptoms:
- Dizziness and light-headedness
- Nausea and vomiting
- Headache
- Fatigue, lethargy, myalgia
- Flu-like symptoms
- Sensory disturbances
Psychological symptoms:
- Anxiety and agitation
- Irritability
- Crying spells
- Dysphoria
- In severe cases: hallucinations 7
Management of Withdrawal Symptoms
If withdrawal symptoms emerge:
- For mild symptoms: Reassure the patient they are typically transient and self-limiting 6
- For moderate to severe symptoms: Reinstitute the previous dose and slow the taper rate 6
- Consider hyperbolic tapering strips if available—these allow daily tiny dose reductions and have shown 72% success rates in real-world discontinuation attempts 8
Special Considerations
High-Risk Situations
Venlafaxine has a short half-life, making it particularly prone to withdrawal symptoms compared to longer half-life antidepressants like fluoxetine 9, 6. Patients may experience withdrawal after missing even a single dose 7.
Risk factors for more difficult tapering 5:
- Female sex
- Younger age
- Longer duration of antidepressant use (median 5-10 years in successful tapers)
- Multiple previous unsuccessful discontinuation attempts
- Faster taper rates
Concurrent Medications
If the patient is also taking benzodiazepines, taper the venlafaxine first before addressing benzodiazepine discontinuation, as benzodiazepine withdrawal carries greater risks and tapering opioids/SNRIs can increase anxiety 10.
Common Pitfalls to Avoid
- Do not abruptly discontinue: This frequently causes severe withdrawal 7, 6
- Do not use ultrarapid detoxification: This is associated with substantial risks including death 3
- Do not mistake withdrawal for relapse or physical illness: Misdiagnosis leads to unnecessary testing and inappropriate treatment 6
- Do not assume a 2-week taper is sufficient: While one study showed similar discontinuation rates between 3-day and 14-day tapers 9, more recent evidence supports much slower tapers over weeks to months 3, 5
Practical Implementation
Starting doses for tapering (working backward from maintenance dose):
- From 225 mg/day: reduce by approximately 22.5 mg per week (10% reduction)
- From 150 mg/day: reduce by approximately 15 mg per week
- From 75 mg/day: reduce by approximately 7.5 mg per week
For patients who have struggled with previous attempts, consider hyperbolic tapering with daily reductions over 2-3 months or longer 5, 8. Current real-world data shows only 8.9% of patients receive evidence of deliberate tapering through the lowest available dose 4, suggesting this critical step is often omitted in routine practice.